Substituted 3,4-dihydroisoquinolin-1(2h)-one derivatives and related uses
AssigneeNodThera Limited
InventorsMark G. BOCK, David HARRISON, Jane E. SCANLON
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to compounds of Formula (I): and to their pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for inhibiting the maturation of cytokines of the IL-1 family by inhibiting inflammasomes and may be used in the treatment of disorders in which inflammasome activity is implicated, such as inflammatory, autoinflammatory and autoimmune diseases and cancers.
Claims42
A compound of Formula (I):
- or a prodrug, solvate, or pharmaceutically acceptable salt thereof, wherein:
- each is independently a single bond or double bond as valency allows;
- A2 is CR2, N, NR2a, O, or S, as valency allows;
- A3 is CR2, N, NR2a, O, or S, as valency allows;
- A4 is CR2, N, NR2a, O, or S, as valency allows;
- A5 is C or N, as valency allows,
- wherein at least one of A2, A3, A4, or As is N, NR2a, O, or S;
- R1 is H, —N(C1-C6 alkyl)2, C1-C6 alkyl, C2-C6 alkenyl, or C3-C12 cycloalkyl, wherein the —N(C1-C6 alkyl)2, C1-C6 alkyl, C2-C6 alkenyl, or C3-C12 cycloalkyl is optionally substituted with one or more R1S;
- each R1S independently is halogen, cyano, —OH, or C1-C6 alkyl;
- R1a is H or C1-C6 alkyl, or
- R1 and R1a together with the atoms to which they are attached form C2-C6 alkenyl, C3-C7 cycloalkyl, or 3- to 7-membered heterocycloalkyl, or
- R1a and R3 together with the atoms to which they are attached form a C3-C12 cycloalkyl or 3- to 12-membered heterocycloalkyl;
- each R2 independently is H, halogen, cyano, —OH, —NH2, —NO2, —C(═O)NH2, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —O(C1-C6 alkyl), —NH(C1-C6 alkyl), —N(C1-C6 alkyl)2, C3-C12 cycloalkyl, 3- to 12-membered heterocycloalkyl, C6-C10 aryl, or 5- to 10-membered heteroaryl, wherein the C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —O(C1-C6 alkyl), —NH(C1-C6 alkyl), —N(C1-C6 alkyl)2, C3-C12 cycloalkyl, 3- to 12-membered heterocycloalkyl, C6-C10 aryl, or 5- to 10-membered heteroaryl is optionally substituted with one or more R2S,
- or two R2 together with the atoms to which they are attached form a C3-C12 cycloalkyl, 3-to 12-membered heterocycloalkyl, C6-C10 aryl, or 5- to 10-membered heteroaryl, wherein the C3-C12 cycloalkyl, 3- to 12-membered heterocycloalkyl, C6-C10 aryl, or 5- to 10-membered heteroaryl is optionally substituted with one or more R2S;
- each R2S independently is halogen, C1-C6 alkyl, —OH, —O(C1-C6 alkyl), —NH(C1-C6 alkyl), —N(C1-C6 alkyl)2, or C3-C12 cycloalkyl;
- R3 is H, —N(C1-C6 alkyl)2, C1-C6 alkyl, C2-C6 alkenyl, or C3-C12 cycloalkyl, wherein the —N(C1-C6 alkyl)2, C1-C6 alkyl, C2-C6 alkenyl, or C3-C12 cycloalkyl is optionally substituted with one or more R1S, or
- R1 and R3 together with the atoms to which they are attached form a C3-C12 cycloalkyl or 3- to 12-membered heterocycloalkyl;
- each R1S independently is halogen, cyano, —OH, or C1-C6 alkyl;
- each R2a independently is H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, —(CH2)0-3—(C3-C12 cycloalkyl), or —(CH2)0-3-(3- to 12-membered heterocycloalkyl);
- each Ra independently is H or C1-C6 alkyl;
- or two Ra, together with the atom they attach to, form C2-C6 alkenyl or C3-C12 cycloalkyl;
- RN1 is H or C1-C6 alkyl;
- RN2 is C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —O—(C1-C6 alkyl), —O—(C2-C6 alkenyl), —O—(C2-C6 alkynyl), —NH—(C1-C6 alkyl), —NH—(C2-C6 alkenyl), —NH—(C2-C6 alkynyl), C3-C12 cycloalkyl, 3- to 12-membered heterocycloalkyl, C6-C10 aryl, 5- to 10-membered heteroaryl, —(C1-C6 alkyl)-(C3-C12 cycloalkyl), —(C1-C6 alkyl)-(3- to 12-membered heterocycloalkyl), —(C1-C6 alkyl)-(C6-C10 aryl), or —(C1-C6 alkyl)-(5- to 10-membered heteroaryl);
- wherein the C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —O—(C1-C6 alkyl), —O—(C2-C6 alkenyl), —O—(C2-C6 alkynyl), —NH—(C1-C6 alkyl), —NH—(C2-C6 alkenyl), —NH—(C2-C6 alkynyl), C3-C12 cycloalkyl, 3- to 12-membered heterocycloalkyl, C6-C10 aryl, 5- to 10-membered heteroaryl, —(C1-C6 alkyl)-(C3-C12 cycloalkyl), —(C1-C6 alkyl)-(3- to 12-membered heterocycloalkyl), —(C1-C6 alkyl)-(C6-C10 aryl), or —(C1-C6 alkyl)-(5- to 10-membered heteroaryl) is optionally substituted with one or more RN2a;
- each RN2a independently is oxo, halogen, cyano, —OH, —NH2, —NO2, —C(═O)H, —C(═O)OH, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —O(C1-C6 alkyl), —NH(C1-C6 alkyl), —N(C1-C6 alkyl)2, —C(═O)(C1-C6 alkyl), —C(═O)O(C1-C6 alkyl), —NHC(═O)O(C1-C6 alkyl), —S(═O)2(C1-C6 alkyl), —S(═O)2N(C1-C6 alkyl)2, C3-C12 cycloalkyl, 3- to 12-membered heterocycloalkyl, C6-C10 aryl, 5- to 10-membered heteroaryl, —(C1-C6 alkyl)-(C3-C12 cycloalkyl), —(C1-C6 alkyl)-(3- to 12-membered heterocycloalkyl), —(C1-C6 alkyl)-(C6-C10 aryl), or —(C1-C6 alkyl)-(5- to 10-membered heteroaryl);
- wherein the C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, —O(C1-C6 alkyl), —NH(C1-C6 alkyl), —N(C1-C6 alkyl)2, —C(═O)(C1-C6 alkyl), —C(═O)O(C1-C6 alkyl), —NHC(═O)O(C1-C6 alkyl), —S(═O)2(C1-C6 alkyl), —S(═O)2N(C1-C6 alkyl)2, C3-C12 cycloalkyl, 3- to 12-membered heterocycloalkyl, C6-C10 aryl, 5- to 10-membered heteroaryl, —(C1-C6 alkyl)-(C3-C12 cycloalkyl), —(C1-C6 alkyl)-(3- to 12-membered heterocycloalkyl), —(C1-C6 alkyl)-(C6-C10 aryl), or —(C1-C6 alkyl)-(5- to 10-membered heteroaryl) is optionally substituted with one or more RN2ab;
- and
- each RN2ab independently is oxo, halogen, cyano, —OH, —NH2, —C(═O)H, —C(═O)OH, —O(C1-C6 alkyl), —NH(C1-C6 alkyl), —N(C1-C6 alkyl)2, —C(═O)(C1-C6 alkyl), —C(═O)O(C1-C6 alkyl), —NHC(═O)O(C1-C6 alkyl), —S(═O)2(C1-C6 alkyl), or —S(═O)2N(C1-C6 alkyl)2;
- or
- RN1 and RN2, together with the atom they attach to, form 3- to 12-membered heterocycloalkyl optionally substituted with one or more Rb;
- each Rb independently is oxo, halogen, cyano, —OH, —NH2, —C(═O)H, —C(═O)OH, C1-C6 alkyl, —O(C1-C6 alkyl), —NH(C1-C6 alkyl), —N(C1-C6 alkyl)2, —C(═O)(C1-C6 alkyl), —C(═O)O(C1-C6 alkyl), —NHC(═O)O(C1-C6 alkyl), —S(═O)2(C1-C6 alkyl), or —S(═O)2N(C1-C6 alkyl)2, wherein the C1-C6 alkyl, —O(C1-C6 alkyl), —NH(C1-C6 alkyl), —N(C1-C6 alkyl)2, —C(═O)(C1-C6 alkyl), —C(═O)O(C1-C6 alkyl), —NHC(═O)O(C1-C6 alkyl), —S(═O)2(C1-C6 alkyl), or —S(═O)2N(C1-C6 alkyl)2 is optionally substituted with one or more Rb1;
- and
- each Rb1 independently is oxo, halogen, cyano, —OH, or —NH2.
The compound of any one of the preceding claims, wherein R1 is H.
The compound of any one of the preceding claims, wherein R1a is H or methyl.
The compound of any one of the preceding claims, wherein R2 is H, C1-C6 alkyl, —O—(C1-C6 alkyl), —NH—(C1-C6 alkyl), or C3-C12 cycloalkyl, or two R2 together with the atoms to which they are attached form 5- to 10-membered heteroaryl optionally substituted with one or more R2S.
The compound of any one of the preceding claims, wherein at least one R2S is halogen or C1-C6 alkyl.
The compound of any one of the preceding claims, wherein R2a is H or C1-C6 alkyl.
The compound of any one of the preceding claims, wherein:
- R3 is H;
- or
- R3 is C1-C6 alkyl;
- or
- R3 is methyl;
- or
- R3 and R1a together with the atoms to which they are attached form C3-C7 cycloalkyl;
- or
- R3 and R1a together with the atoms to which they are attached form cyclopropyl;
- or
- R3 and R1 together with the atoms to which they are attached form C3-C7 cycloalkyl;
- or
- R3 and R1 together with the atoms to which they are attached form cyclopropyl.
The compound of any one of the preceding claims, wherein at least one Ra is H.
The compound of any one of the preceding claims, wherein both Ra are H.
The compound of any one of the preceding claims, wherein RN1 is H.
The compound of any one of the preceding claims, wherein RN2 is C3-C12 cycloalkyl, 3- to 12-membered heterocycloalkyl, or 5- to 10-membered heteroaryl;
- wherein the C3-C12 cycloalkyl, 3- to 12-membered heterocycloalkyl, or 5- to 10-membered heteroaryl is optionally substituted with one or more RN2a.
The compound of any one of the preceding claims, wherein RN2 is
The compound of any one of the preceding claims, wherein at least one RN2a is oxo, F, Cl, cyano, —OH, —NH2, —NO2, methyl, CF3, —O(methyl), —C(═O)O(ethyl), or pyrazolyl.
The compound of any one of the preceding claims, wherein the compound is of Formula (II):
- or a prodrug, solvate, or pharmaceutically acceptable salt thereof.
The compound of any one of the preceding claims, wherein the compound is selected from the compounds described in Table 1, or a prodrug or pharmaceutically acceptable salt thereof.
A compound being an isotopic derivative of the compound of any one of the preceding claims.
A compound obtainable by, or obtained by, a method described herein.
A pharmaceutical composition comprising the compound of any one of the preceding claims and a pharmaceutically acceptable diluent or carrier.
Dependencies are inferred from the claim text.